Profound Medical Corp reports results for the quarter ended December 31 - Earnings Summary

• Profound Medical Corp PRN.TO reported a quarterly adjusted loss of 20 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -42 cents. The mean expectation of three analysts for the quarter was for a loss of 35 cents per share. Wall Street expected results to range from -39 cents to -30 cents per share.

• Revenue rose 107.9% to $4.18 million from a year ago; analysts expected $4.27 million.

• Profound Medical Corp's reported EPS for the quarter was a loss of 20 cents​.

• The company reported a quarterly loss of $4.95 million.

• Profound Medical Corp shares had fallen by 4.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Profound Medical Corp is C$24.42

This summary was machine generated from LSEG data March 7 at 01:33 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)